InvestorsHub Logo
Followers 25
Posts 3482
Boards Moderated 0
Alias Born 08/21/2014

Re: None

Monday, 08/14/2017 9:53:13 AM

Monday, August 14, 2017 9:53:13 AM

Post# of 462734
From December 29th 2015 PR regarding upcoming milestones:

"Initiate double-blinded, randomized, placebo-controlled Phase 2 human trial of ANAVEX 2-73 in non-disclosed indication."

All we can say that this non-disclosed indication is Rett, but that is it. I guess it depends on how flexible one is with the time concept of "upcoming"

Oh and this was an upcoming milestone too:

"In-licensing to complement current pipeline – ongoing"

Anyone any news?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News